Cerenome, Inc. (CNSY)
NASDAQ: CNSY · Real-Time Price · USD
1.670
-0.030 (-1.76%)
Oct 19, 2026, 9:49 AM EDT - Market open
Cerenome Employees
Cerenome had 28 employees as of December 31, 2025. The number of employees increased by 7 or 33.33% compared to the previous year. That makes Cerenome the 37,275th largest employer in the world and 5,203rd in the United States.
Employees
28
Change (1Y)
7
Growth (1Y)
33.33%
Revenue / Employee
$150,107
Profits / Employee
-$931,714
Market Cap
12.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 7 | 33.33% |
| Dec 31, 2024 | 21 | 1 | 5.00% |
| Dec 31, 2023 | 20 | 3 | 17.65% |
| Dec 31, 2022 | 17 | 3 | 21.43% |
| Dec 31, 2021 | 14 | 2 | 16.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Palatin Technologies | 25 |
| Daré Bioscience | 24 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Lipocine | 14 |
| Radiopharm Theranostics | 14 |
| Tvardi Therapeutics | 12 |
| Allarity Therapeutics | 8 |
CNSY News
- 11 days ago - Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests - GlobeNewsWire
- 13 days ago - Cerenome Launches CNSide® CSF Molecular Profile Tests - GlobeNewsWire
- 17 days ago - Cerenome Slides: Investor presentation - Filings
- 18 days ago - Cerenome price target lowered to $31 from $50 at Lake Street - TheFly
- 19 days ago - Cerenome Transcript: Investor update - Transcripts
- 19 days ago - Cerenome Press release: Investor update - Filings
- 19 days ago - Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings - GlobeNewsWire
- 24 days ago - Cerenome to Hold CNSide® Business Update Call on September 30, 2026 - GlobeNewsWire